Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2023 Financial Results
Go back to Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2023 Financial Results| (NASDAQ: CRVS) | Delayed: 12.13 +0.53 (4.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.60 | 52 Week High | $17.77 | |||
| Open | $11.52 | 52 Week Low | $9.63 | |||
| Day High | $12.27 | P/E | N/A | |||
| Day Low | $11.50 | EPS | $0.00 | |||
| Volume | 291,455 | |||||

